Para quién es esta clase: The target audience consists of health care practitioners in the fields of gastroenterology, medical oncology, pathology, psychiatry, pulmonary medicine, radiation oncology, radiology, and thoracic surgery. The course should be of interest to practicing physicians, doctors in training (e.g. senior medical students, residents, fellows), and other clinicians, including nurse practitioners, physician assistants, etc. The core curriculum will give learners a base of knowledge and understanding to draw and build upon in their day to day clinical activities in thoracic cancer care.


Creada por:   Universidad de Míchigan

LevelAdvanced
Commitment7 weeks of study, 2-4 hours/week
Language
English
How To PassPass all graded assignments to complete the course.
User Ratings
4.9 stars
Average User Rating 4.9See what learners said
Programa

Preguntas Frecuentes
Cómo funciona
Trabajo del curso
Trabajo del curso

Cada curso es como un libro de texto interactivo, con videos pregrabados, cuestionarios y proyectos.

Ayuda de tus compañeros
Ayuda de tus compañeros

Conéctate con miles de estudiantes y debate ideas y materiales del curso, y obtén ayuda para dominar los conceptos.

Certificados
Certificados

Obtén reconocimiento oficial por tu trabajo y comparte tu éxito con amigos, compañeros y empleadores.

Creadores
Universidad de Míchigan
The mission of the University of Michigan is to serve the people of Michigan and the world through preeminence in creating, communicating, preserving and applying knowledge, art, and academic values, and in developing leaders and citizens who will challenge the present and enrich the future.
Calificaciones y revisiones
Calificado 4.9 de 5 31 calificaciones

Excellent course .

A very comprehensive overview of lung and esophageal cancer, from risk factors, to diagnosis, staging, surgery, palliative care, psychological support and pain management. I thoroughly enjoyed participating in this excellently presented course.

As a pediatric oncologist, I have not had to deal with either lung or esophageal cancers.

The use of endoscopic analysis for determining lymph node involvement was quite an eye-opener.

Likewise, the immunologic histochemical variation was a valuable learning experience as were the

pathologic descriptions of adenoca variants.

The only possible criticism might be the thoracic surgeons use of acronyms without explanation, but

this was minor.

Kudos to the team

Gratefully Gerald Vladimer MD

Very important, helpful and very very well done. Thanks a lot